Cell Medx Corp. (CMXC) 0.6900 $CMXC
Cell MedX Corp. (CMXC), Announces the formation of an Advisory Board with John Sanderson MD as Chairman
Marketwired - Tue Nov 11, 7:04AM CST
Cell MedX Corp. (OTCBB: CMXC), (the "Company"

announces the formation of an Advisory Board with Dr. John Sanderson MD as its Chairman. Dr. Sanderson will be organizing the development team and protocols necessary to advance the development of the Company's proposed technology, including the clinical trial phases and oversight of the results of those trials. Dr. Sanderson is accepting this appointment as an interim position in the anticipation of joining the Company as its Chief Medical Director. Dr. Sanderson is a stem cell researcher who began his career in clinical medicine specializing in diabetes and intravenous nutrition of critically ill patients. He has received NIH funding, has multiple issued patents and published numerous academic papers as principal investigator. While a medical director and consultant at Johnson & Johnson, Dr. Sanderson was tasked with due diligence oversight for mergers and acquisitions, formulating strategic initiatives, and evaluating new technologies. As a consultant to Fortune 100 health care companies and the U.S. government, Dr. Sanderson worked with some of the greatest minds of the day devising technological solutions to important public health challenges such as obesity, diabetes, and asthma.
Cell MedX Corp. Announces Signing of Definitive Agreement to Acquire Technology for Treating Diabetes and Related Ailments
Marketwired - Fri Oct 17, 8:02AM CDT
Cell MedX Corp. (OTCBB: CMXC), (the "Company"

is pleased to announce that on October 16, 2014, the Company entered into a Technology Purchase Agreement with Jean Arnett and Brad Hargreaves (collectively being the "Vendors"

to acquire a proprietary technology for treatment of diabetes and related ailments (the "Technology"

. The Purchase Agreement replaces and supersedes the binding letter agreement dated August 29, 2014, pursuant to which the Vendors had previously agreed to grant to the Company exclusive worldwide license rights for the Technology.
Sports Asylum, Inc. Announces Name Change to Cell MedX Corp.
Marketwired - Wed Oct 08, 4:12PM CDT
Sports Asylum, Inc. (OTCBB: SYLM) (the "Company"

is pleased to announce that effective October 9, 2014, the Company will change its name to "Cell MedX Corp." (the "Name Change"

.